Milestone Pharmaceuticals (MIST) Free Cash Flow: 2021-2022
Historic Free Cash Flow for Milestone Pharmaceuticals (MIST) over the last 2 years, with Dec 2022 value amounting to -$13.0 million.
- Milestone Pharmaceuticals' Free Cash Flow fell 4.81% to -$13.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$52.7 million, marking a year-over-year decrease of 58.57%. This contributed to the annual value of -$28.9 million for FY2024, which is 37.94% up from last year.
- Milestone Pharmaceuticals' Free Cash Flow amounted to -$13.0 million in Q4 2022, which was down 11.10% from -$11.7 million recorded in Q3 2022.
- Over the past 5 years, Milestone Pharmaceuticals' Free Cash Flow peaked at $1.0 million during Q2 2021, and registered a low of -$14.1 million during Q2 2022.
- Over the past 2 years, Milestone Pharmaceuticals' median Free Cash Flow value was -$12.4 million (recorded in 2021), while the average stood at -$10.7 million.
- Data for Milestone Pharmaceuticals' Free Cash Flow shows a maximum YoY slumped of 1,487.68% (in 2022) over the last 5 years.
- Over the past 2 years, Milestone Pharmaceuticals' Free Cash Flow (Quarterly) stood at -$12.4 million in 2021, then dropped by 4.81% to -$13.0 million in 2022.
- Its Free Cash Flow stands at -$13.0 million for Q4 2022, versus -$11.7 million for Q3 2022 and -$14.1 million for Q2 2022.